Últimas noticias sobre Creative Realities (NASDAQ:CREX) Bolsa

Creative Realities

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

Earnings

Pre-Market Outlook

Markets

Trading Ideas

CREX

MSFT

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: CMC, FF, CREX, BA y MSFT.

5 acciones en el foco este lunes: CMC, FF, CREX, BA y MSFT

Creative Realities Inc

Creative Realities Inc Warrants (09/11/2022)

Crexendo Inc

Tools for Humanity, co-founded by OpenAI CEO <a href="https://www.benzinga.com/news/25/04/44645905/sam-altman-jokes-about-openais-viral-ai-tool-i-worked-10-years-on-superintelligence-and-people-just-turn-themselves-into-ghibli-characters">Sam Altman</a>, officially launched its biometric identity verification system, World, previously known as Worldcoin, in the U.S. on May 1.
This launch introduces the Orb Mini, a portable device designed to scan users&#8217; irises and generate a unique World identifier, stored on the blockchain, according to<a href="https://techcrunch.com/2025/04/30/sam-altmans-world-unveils-a-mobile-verification-device/"> </a>a <a href="https://world.org/blog/announcements/world-launches-in-the-usa-at-last">statement</a>. The initiative aims to address the growing challenge of distinguishing humans from <a href="https://www.benzinga.com/news/25/04/45014781/adobe-invests-in-2-1b-ai-unicorn-synthesia-as-openais-sora-competes-in-the-race-for-ai-generated-video-dominance">AI</a>-generated entities online.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Alex Blania's Role and the National Rollout of Orb Mini Devices</h2>
The company is led by co-founder and CEO Alex Blania, who frequently speaks at major tech and privacy events to advocate for the company's vision,<a href="https://world.org/blog/announcements/international-engagement-scales-meet-global-interest-worldcoin"> according to World</a>. In a LinkedIn<a href="https://www.linkedin.com/posts/alex-blania-b8444aa0_this-week-what-started-as-worldcoin-became-activity-7253944214915309568-1Ty5/"> post</a>, Blania introduced the rebranding of Worldcoin to World, outlining the company's vision to build a global human network through identity verification, financial tools, and community, while unveiling World ID 3.0, the redesigned Orb device, and World Chain, a blockchain prioritizing human-validated transactions.
According to<a href="https://www.theverge.com/cryptocurrency/659011/worldcoin-us-launch-orb-crypto-sam-altman"> The Verge</a>, the Orb Mini resembles a smartphone with prominent eye sensors and is a scaled-down version of the original Orb device. It is designed for portability and ease of use, facilitating broader adoption of the World ID system. The device was unveiled at the At Last event in San Francisco, where Tools for Humanity also announced plans to distribute 7,500 Orb devices across the U.S. by the end of the year, as reported by<a href="https://www.wired.com/story/sam-altman-orb-eyeball-scan-launch-us/"> Wired</a>.
Trending: Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.
<h2 class="wp-block-heading">Strategic Partnerships and Expansion</h2>
According to Wired, Tools for Humanity has formed strategic partnerships with Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), Match Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>), and Razer to expand the reach of its World ID system across industries such as finance, dating, and gaming.&nbsp;
Visa is collaborating with the startup on a debit card connected to the World App, enabling users to spend Worldcoin like traditional currency, while Match is piloting age verification for Tinder users in Japan, with possible expansion to other platforms under its umbrella, Wired reports.
According to The Verge, the U.S. rollout includes storefronts in six cities: San Francisco, Los Angeles, Miami, Atlanta, Austin, and Nashville. These locations offer iris scanning services to generate World IDs, with users receiving 16 WLD tokens upon verification. As reported by Wired, the company says that over 26 million people have signed up globally, with 12 million users verified through the system.
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a>
<h2 class="wp-block-heading">Privacy Concerns and Regulatory Scrutiny</h2>
Despite its ambitious goals, Tools for Humanity faces scrutiny over privacy and data security. The company<a href="https://world.org/faqs"> asserts</a> that biometric data collected during the iris scan is encrypted, sent to the user&#8217;s device, and immediately deleted from the Orb. No personal data is stored on the device or shared with third parties.
However, regulatory challenges have emerged in several countries. According to<a href="https://www.bloomberg.com/news/articles/2024-04-25/eyeball-scanning-worldcoin-project-looks-to-openai-partnership?sref=4TStDRR2"> Bloomberg</a>, operations have been suspended or restricted in regions like Kenya, Hong Kong, and South Korea due to concerns over data privacy and the ethical implications of incentivizing biometric data collection with cryptocurrency.
In response to ongoing scrutiny from privacy regulators, Tools for Humanity has open-sourced much of the Orb's technology to allow third parties to verify its safety claims,<a href="https://edition.cnn.com/2025/04/21/tech/orb-tools-for-humanity-sam-altman-human-verification/"> CNN</a> reports.
As Tools for Humanity continues its expansion, the success of the Orb Mini and World ID system will depend on public trust and the company&#8217;s ability to navigate complex regulatory landscapes. The initiative may represent a step toward establishing digital identities in an increasingly AI-driven world.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

News

MTCH

Worldcoin's Orb Mini Launches In U.S. Backed By Sam Altman, Visa, And Match Group To Distinguish Humans from AI

Leidos Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) reported <a href="https://www.benzinga.com/pressreleases/25/05/n45215692/leidos-posts-strong-first-quarter-results-and-reaffirms-full-year-guidance" target="_blank" rel="noreferrer noopener">first-quarter fiscal 2025</a> results on Tuesday. The company reported a quarterly revenue growth of 7% year-over-year to $4.25 billion, beating the analyst consensus estimate of $4.10 billion. The stock price gained after the report.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43627586/leidos-q4-earnings-76-billion-in-net-bookings-ceo-highlights-business-momentum-and-2025-outlook" rel="noreferrer noopener">Leidos Q4 Earnings: $7.6 Billion In Net Bookings, CEO Highlights Business Momentum And 2025 Outlook</a>
Revenues grew year-over-year due to increased demand across all customer segments, with three of the four reporting segments growing 7% or more.
The defense, aviation, information technology and biomedical research, the company's adjusted EPS was $2.97, up 30% Y/Y, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate</a> of $2.50.
Adjusted net income was $391 million for the quarter, up 25% Y/Y.
Adjusted EBITDA was $601 million, up 23% Y/Y. The margin of 14.2% increased from 12.3% a year ago.&nbsp;
Net bookings totaled $2.1 billion for the quarter, representing a book-to-bill ratio of 0.5.&nbsp;As a result, the backlog at the end of the year was $46.3 billion, of which $7.3 billion was funded.&nbsp;
Leidos held $842 million in cash and equivalents as of April&nbsp;4, 2025.
Outlook:&nbsp;Leidos <a target="_blank" href="https://www.benzinga.com/25/02/43627586/leidos-q4-earnings-76-billion-in-net-bookings-ceo-highlights-business-momentum-and-2025-outlook" rel="noreferrer noopener">reiterated fiscal 2025</a> revenue of $16.9 billion–$17.3 billion. The analyst&nbsp;consensus stands&nbsp;at $17.13 billion.
The company expects its fiscal 2024 adjusted EPS of $10.35–$10.75 versus the&nbsp;$10.68 <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">consensus estimate</a>.
LDOS Price Action: Leidos Holding stock is up 4.29% at $154.28 at publication on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45142357/mastercard-raises-guidance-for-fy25-after-upbeat-q1-results-and-surge-in-global-card-issuance" target="_blank" rel="noreferrer noopener">Mastercard Lifts Annual Outlook After Q1 Beat, Fueled By Cross-Border Surge</a></li>
</ul>
Photo: JHVEPhoto via Shutterstock

Guidance

Movers

Tech

LDOS

Leidos Jumps On Q1 Beat As Defense, Tech Demand Fuel Growth, 2025 Outlook Reaffirmed

Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) has outperformed the market over the past 15 years by 1.8% on an annualized basis producing an average annual return of 12.79%. Currently, Allstate has a market capitalization of $53.36 billion. 
Buying $1000 In ALL: If an investor had bought $1000 of ALL stock 15 years ago, it would be worth $6,145.34 today based on a price of $201.26 for ALL at the time of writing.
<h3>Allstate's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746549918_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Needham analyst Chris Pierce maintains TrueCar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUE#NASDAQ">TRUE</a>) with a Buy and lowers the price target from $4 to $2.75.

Price Target

Analyst Ratings

TRUE

Needham Maintains Buy on TrueCar, Lowers Price Target to $2.75

<a href="https://www.youtube.com/watch?v=CuRS6FT95qc" title="https://www.youtube.com/watch?v=CuRS6FT95qc">https://www.youtube.com/watch?v=CuRS6FT95qc</a>

Macro Economic Events

Politics

Global

Economics

General

STLA

President Trump Says We Don't Really Want Cars From Canada; At Some Point It Won't Make Economic Sense For Canada To Build Those Cars; There Is No Reason For Us To Subsidize Canada; We Protect Canada Militarily And We Always Will

Needham analyst Ryan MacDonald reiterates Talkspace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TALK#NASDAQ">TALK</a>) from Hold to Hold.

Reiteration

TALK

Needham Reiterates Hold on Talkspaceto Hold

AVGO

TSLA

Live On CNBC, Bill Baruch Announces Trimmed Broadcom Position; Bought More Tesla

<a href="https://www.washingtonpost.com/climate-environment/2025/05/06/energy-star-program-epa-trump/" title="https://www.washingtonpost.com/climate-environment/2025/05/06/energy-star-program-epa-trump/">https://www.washingtonpost.com/climate-environment/2025/05/06/energy-star-program-epa-trump/</a>

JELD

'Trump Administration Plans To End Energy Star Program For Home Appliances' - Washington Post

Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) with a Buy and lowers the price target from $138 to $115.

Stifel Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $115

Stifel analyst Brad Reback maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Buy and raises the price target from $975 to $1050.

Stifel Maintains Buy on ServiceNow, Raises Price Target to $1050

WIIM

VPG stock has given up its prior loss. Vishay Precision Group shares were trading lower after the company reported worse-than-expected Q1 financial results.

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRYS#NASDAQ">KRYS</a>) with a Buy and maintains $240 price target.

KRYS

HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $240 Price Target

Avadel Pharmaceuticals plc (NASDAQ:<a href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>), a biopharmaceutical company focused on transforming medicines to transform lives, today announced that the United States Court of Appeals for the Federal Circuit (the "Federal Circuit") has ruled in favor of Avadel, overturning important parts of the injunction imposed by the U.S. District Court for the District of Delaware (the "Delaware Court") regarding LUMRYZ&#x2122;&nbsp;as a potential treatment of indications beyond narcolepsy.
The Federal Circuit vacated the portion of the injunction that prohibited Avadel from applying for FDA approval of LUMRYZ for any indication beyond narcolepsy, calling the district court's analysis "simply too speculative and tenuous." Additionally, the Federal Circuit lifted the portions of the Delaware Court's injunction that prohibited Avadel from offering open-label extensions to trial participants using LUMRYZ and from initiating new clinical trials or studies with LUMRYZ for potential indications beyond narcolepsy.

Biotech

Legal

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

UPDATE: Federal Circuit Lifted The Portions Of The Delaware Court's Injunction That Prohibited Avadel From Offering Open-Label Extensions To Trial Participants Using LUMRYZ And From Initiating New Clinical Trials Or Studies With LUMRYZ For Potential Indications Beyond Narcolepsy

Canada's PM Carney Says Some Things About USMCA Will Have To Change

Shares of EVgo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>) surged 29.5% to $3.59 on Tuesday following the release of its first-quarter 2025 earnings.
What To Know: The electric vehicle charging network provider <a href="https://www.benzinga.com/pressreleases/25/05/b45217022/evgo-inc-reports-record-first-quarter-2025-results">reported</a> a net loss of 9 cents per share, in line with analyst expectations and unchanged from the prior year. Revenue climbed 36.5% year-over-year to $75.3 million, exceeding estimates of $71.2 million.
The company reaffirmed its full-year revenue guidance of $340–$380 million, aligning with Wall Street's $351.9 million forecast. CEO Badar Khan <a href="https://www.benzinga.com/pressreleases/25/05/b45217022/evgo-inc-reports-record-first-quarter-2025-results">highlighted</a> record revenues and strong infrastructure growth, adding that EVgo remains on track to achieve Adjusted EBITDA breakeven in 2025.
Operationally, EVgo ended the first-quarter with 4,240 active charging stalls, adding over 180 new DC fast chargers. Daily network throughput rose 36% to 266 kWh per stall. The company also added 119,000 new customer accounts, bringing the total to 1.4 million.
EVgo also secured two advances totaling $94 million under its $1.25 billion DOE loan guarantee, supporting the deployment of 7,500 new fast charging stalls nationwide.
Read Also: <a href="https://www.benzinga.com/news/25/05/45226337/hyperscale-data-gpus-stock-falls-after-400-rally-whats-going-on">Hyperscale Data Stock Falls After 400% Rally: What&#8217;s Going On?</a>
<h2 class="wp-block-heading">How To Buy EVGO Stock</h2>
By now you're likely curious about how to participate in the market for EVgo &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of EVgo, which is trading at $3.59 as of publishing time, $100 would buy you 27.86 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, EVGO has a 52-week high of $9.07 and a 52-week low of $1.73.

EVGO

EVgo Stock Explodes After Strong Q1 Results And Revenue Beat

Needham analyst Mike Cikos reiterates DigitalOcean Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCN#NYSE">DOCN</a>) from Hold to Hold.

DOCN

Needham Reiterates Hold on DigitalOcean Holdingsto Hold

Stifel analyst Simon Yarmak maintains Realty Income (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>) with a Buy and raises the price target from $65.5 to $68.

Stifel Maintains Buy on Realty Income, Raises Price Target to $68

Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) has outperformed the market over the past 5 years by 21.65% on an annualized basis producing an average annual return of 35.63%. Currently, Viper Energy has a market capitalization of $5.48 billion. 
Buying $1000 In VNOM: If an investor had bought $1000 of VNOM stock 5 years ago, it would be worth $4,641.97 today based on a price of $41.81 for VNOM at the time of writing.
<h3>Viper Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746549023_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VNOM

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Stifel analyst Benjamin Nolan maintains Matson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MATX#NYSE">MATX</a>) with a Hold and lowers the price target from $160 to $130.

MATX

Stifel Maintains Hold on Matson, Lowers Price Target to $130

RBC Capital analyst Walter Spracklin maintains Westshore Terminals (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WTE#TSX">WTE</a>) with a Sector Perform and lowers the price target from C$25 to C$23.

TSX:WTE

RBC Capital Maintains Sector Perform on Westshore Terminals, Lowers Price Target to C$23

Press Releases

Creative Realities Launches AdLogic CPM+, Delivering a Unified Solution for In-Store Retail Media Networks

Creative Realities Expands into Live Venue and IPTV Verticals, Welcomes Michael Baez as VP of Business Development

Creative Realities, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call Information

Creative Realities Reports Fiscal 2024 Fourth Quarter Results

Creative Realities Announces Reflect Settlement Agreement

Creative Realities Powers Digital Transformation at Rogers Arena, Marking First Major Canadian Sports & Entertainment Deployment

Creative Realities Completes SOC 2 Type 1 Compliance Audit Process

Creative Realities Announces Participation in Upcoming Planet MicroCap Event

Creative Realities Awarded Menu Board and Drive-Through Digital Transformation Project by Upscale QSR Chain

Creative Realities, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Information

CREXW

Able View Global Inc. - Class B Ordinary Shares

Able View Global

AirNet Technology Inc. - American Depositary Shares, each representing one ordinary shares

Comments

Creative Realities

Noticias

Últimas noticias sobre Creative Realities (NASDAQ:CREX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL